Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ferring sdn. bhd. - follitropin delta -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ferring sdn. bhd. - follitropin delta -

New Zealand - English - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - corifollitropin alfa 0.2 mg/ml;   - solution for injection - 100 mcg/0.5ml - active: corifollitropin alfa 0.2 mg/ml   excipient: hydrochloric acid methionine polysorbate 20 sodium citrate sodium hydroxide sucrose water for injection - controlled ovarian stimulation (cos) for the development of multiple follicles and pregnancy in women undergoing in-vitro fertilisation techniques.

New Zealand - English - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - corifollitropin alfa 0.3 mg/ml;   - solution for injection - 150 mcg/0.5ml - active: corifollitropin alfa 0.3 mg/ml   excipient: hydrochloric acid methionine polysorbate 20 sodium citrate sodium hydroxide sucrose water for injection - controlled ovarian stimulation (cos) for the development of multiple follicles and pregnancy in women undergoing in-vitro fertilisation techniques.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - follitropin alfa 600 iu/ml equivalent to 43.68 mcg/ml;   - solution for injection - 600 iu/ml - active: follitropin alfa 600 iu/ml equivalent to 43.68 mcg/ml   excipient: dibasic sodium phosphate dihydrate metacresol methionine monobasic sodium phosphate dihydrate phosphoric acid poloxamer sodium hydroxide sucrose water for injection - gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - follitropin alfa 150 [iu] (rch, + 10% overage);  ; lutropin alfa, rch 75 [iu] (+ 23% overage) - powder for injection - 150 iu/75 iu - active: follitropin alfa 150 [iu] (rch, + 10% overage)   lutropin alfa, rch 75 [iu] (+ 23% overage) excipient: dibasic sodium phosphate dihydrate methionine monobasic sodium phosphate monohydrate phosphoric acid polysorbate 20 sodium hydroxide sucrose water for injection - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh of less than 1.2 iu/l.

New Zealand - English - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - follitropin beta 833 iu/ml;   - solution for injection - 833 iu/ml - active: follitropin beta 833 iu/ml   excipient: benzyl alcohol hydrochloric acid as 0.1n solution to adjust to ph 7.0 methionine polysorbate 20 sodium citrate dihydrate sodium hydroxide as 0.1n solution to adjust to ph 7.0 sucrose water for injection - in the female: - anovulatory infertility - controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programmes [e.g. in vitro fertilisation and related procedures].

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 75 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 150 international unit(s) - gonadotropins; urofollitropin

Ireland - English - HPRA (Health Products Regulatory Authority)

ibsa farmaceutici italia s.r.l - urofollitropin - powder and solvent for solution for injection - 150 international unit(s) - gonadotropins; urofollitropin